{"doi":"10.1016/j.jalz.2018.04.010","title":"Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts","abstract":"<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Our objective was to investigate the effect of sex on cognitive decline within the context of amyloid β (Aβ) burden and apolipoprotein E genotype.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analyzed sex‐specific effects on Aβ‐positron emission tomography, apolipoprotein, and rates of change on the Preclinical Alzheimer Cognitive Composite‐5 across three cohorts, such as the Alzheimer's Disease Neuroimaging Initiative, Australian Imaging, Biomarker and Lifestyle, and Harvard Aging Brain Study (n = 755; clinical dementia rating = 0; age (standard deviation) = 73.6 (6.5); female = 55%). Mixed‐effects models of cognitive change by sex, Aβ‐positron emission tomography, and apolipoprotein ε4 were examined with quadratic time effects over a median of 4 years of follow‐up.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Apolipoprotein ε4 prevalence and Aβ burden did not differ by sex. Sex did not directly influence cognitive decline. Females with higher Aβ exhibited faster decline than males. <jats:italic>Post hoc</jats:italic> contrasts suggested that females who were Aβ and apolipoprotein ε4 positive declined faster than their male counterparts.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>Although Aβ did not differ by sex, cognitive decline was greater in females with higher Aβ. Our findings suggest that sex may play a modifying role on risk of Alzheimer's disease–related cognitive decline.</jats:p></jats:sec>","journal":"Alzheimer's &amp; Dementia","year":2018,"id":591744,"datarank":7.938193546349786,"base_score":5.673323267171493,"endowment":5.673323267171493,"self_citation_contribution":0.850998490075724,"citation_network_contribution":7.087195056274062,"self_endowment_contribution":0.850998490075724,"citer_contribution":7.087195056274062,"corpus_percentile":null,"corpus_rank":null,"citation_count":290,"citer_count":200,"citers_with_citation_signal":180,"citers_with_endowment":180,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":29931,"name":"Elizabeth C. Mormino","orcid":"0000-0002-4542-6537","position":1,"is_corresponding":false},{"id":263296,"name":"Rebecca E. Amariglio","orcid":"0009-0009-5878-8930","position":2,"is_corresponding":false},{"id":1514108,"name":"Michael J. Properzi","orcid":null,"position":3,"is_corresponding":false},{"id":443329,"name":"Jennifer S. Rabin","orcid":"0000-0003-4754-2221","position":4,"is_corresponding":false},{"id":301878,"name":"Yen Ying Lim","orcid":"0000-0002-0308-5156","position":5,"is_corresponding":false},{"id":313457,"name":"Kathryn V. Papp","orcid":"0000-0003-1687-4370","position":6,"is_corresponding":false},{"id":263294,"name":"Heidi I.L. Jacobs","orcid":"0000-0001-7620-3822","position":7,"is_corresponding":false},{"id":1514112,"name":"Samantha Burnham","orcid":null,"position":8,"is_corresponding":false},{"id":1514113,"name":"Bernard J. Hanseeuw","orcid":null,"position":9,"is_corresponding":false},{"id":236166,"name":"Vincent Doré","orcid":"0000-0002-8051-0558","position":10,"is_corresponding":false},{"id":1514114,"name":"Annette Dobson","orcid":null,"position":11,"is_corresponding":false},{"id":230035,"name":"Colin L. Masters","orcid":"0000-0003-3072-7940","position":12,"is_corresponding":false},{"id":1362360,"name":"Michael Waller","orcid":null,"position":13,"is_corresponding":false},{"id":55007,"name":"Christopher C. Rowe","orcid":"0000-0003-3910-2453","position":14,"is_corresponding":false},{"id":230036,"name":"Paul Maruff","orcid":"0000-0002-6947-9537","position":15,"is_corresponding":false},{"id":51708,"name":"Michael C. Donohue","orcid":null,"position":16,"is_corresponding":false},{"id":68026,"name":"Dorene M. Rentz","orcid":null,"position":17,"is_corresponding":false},{"id":468550,"name":"Dylan Kirn","orcid":null,"position":18,"is_corresponding":false},{"id":67969,"name":"Trey Hedden","orcid":null,"position":19,"is_corresponding":false},{"id":845115,"name":"Jasmeer Chhatwal","orcid":null,"position":20,"is_corresponding":false},{"id":263295,"name":"Aaron P. Schultz","orcid":"0000-0002-0418-0999","position":21,"is_corresponding":false},{"id":598406,"name":"Keith A. Johnson","orcid":"0000-0001-6404-4780","position":22,"is_corresponding":false},{"id":236168,"name":"Victor L. Villemagne","orcid":"0000-0002-5832-9875","position":23,"is_corresponding":false},{"id":55000,"name":"Reisa A. Sperling","orcid":"0000-0003-1535-6133","position":24,"is_corresponding":false},{"id":261846,"name":"Rachel F. Buckley","orcid":"0000-0002-5356-5537","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts","abstract":"<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Our objective was to investigate the effect of sex on cognitive decline within the context of amyloid β (Aβ) burden and apolipoprotein E genotype.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analyzed sex‐specific effects on Aβ‐positron emission tomography, apolipoprotein, and rates of change on the Preclinical Alzheimer Cognitive Composite‐5 across three cohorts, such as the Alzheimer's Disease Neuroimaging Initiative, Australian Imaging, Biomarker and Lifestyle, and Harvard Aging Brain Study (n = 755; clinical dementia rating = 0; age (standard deviation) = 73.6 (6.5); female = 55%). Mixed‐effects models of cognitive change by sex, Aβ‐positron emission tomography, and apolipoprotein ε4 were examined with quadratic time effects over a median of 4 years of follow‐up.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Apolipoprotein ε4 prevalence and Aβ burden did not differ by sex. Sex did not directly influence cognitive decline. Females with higher Aβ exhibited faster decline than males. <jats:italic>Post hoc</jats:italic> contrasts suggested that females who were Aβ and apolipoprotein ε4 positive declined faster than their male counterparts.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>Although Aβ did not differ by sex, cognitive decline was greater in females with higher Aβ. Our findings suggest that sex may play a modifying role on risk of Alzheimer's disease–related cognitive decline.</jats:p></jats:sec>","is_dataset_classified":null,"base_score":5.673323267171493,"endowment":5.673323267171493,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29803541","pmcid":"PMC6131023","openalex_id":"https://openalex.org/W2803902280","authors":[],"funders":[{"funder_name":"Alzheimer Nederland","grant_id":"WE.15-2014-06","title":null},{"funder_name":"National Institutes of Health","grant_id":"K01 040197","title":null},{"funder_name":"National Institutes of Health","grant_id":"P01 AG036694","title":null},{"funder_name":"National Institutes of Health","grant_id":"P50 AG005134","title":null},{"funder_name":"National Institutes of Health","grant_id":"K23 EB019023","title":null},{"funder_name":"National Institutes of Health","grant_id":"K23 AG049087","title":null},{"funder_name":"National Institutes of Health","grant_id":"K24 AG035007","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01EB014894","title":null},{"funder_name":"National Institutes of Health","grant_id":"R21 AG038994","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01 AG026484","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01 AG034556","title":null},{"funder_name":"National Institutes of Health","grant_id":"P50 AG00513421","title":null},{"funder_name":"National Institutes of Health","grant_id":"U19 AG10483","title":null},{"funder_name":"National Institutes of Health","grant_id":"R13 AG042201174210","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01 AG027435","title":null},{"funder_name":"National Institutes of Health","grant_id":"R01 AG037497","title":null},{"funder_name":"U.S. Department of Defense","grant_id":"W81XWH-12-2-0012","title":null},{"funder_name":"Alzheimer's Association","grant_id":"ZEN-10-174210","title":null},{"funder_name":"Eli Lilly and Company","grant_id":"U01 AG032438","title":null},{"funder_name":"Eli Lilly and Company","grant_id":"U01 AG024904","title":null},{"funder_name":"Eli Lilly and Company","grant_id":"U19 AG010483","title":null},{"funder_name":"NIA NIH HHS","grant_id":"U01 AG010483","title":null},{"funder_name":"NIBIB NIH HHS","grant_id":"P41 EB015896","title":null},{"funder_name":"NIA NIH HHS","grant_id":"U19 AG024904","title":null},{"funder_name":"NCRR NIH HHS","grant_id":"S10 RR023401","title":null},{"funder_name":"NIA NIH HHS","grant_id":"U19 AG032438","title":null},{"funder_name":"NCRR NIH HHS","grant_id":"S10 RR021110","title":null},{"funder_name":"NCRR NIH HHS","grant_id":"S10 RR023043","title":null},{"funder_name":"National Institute of Biomedical Imaging and Bioengineering","grant_id":"","title":null},{"funder_name":"National Institute on Aging","grant_id":"","title":null},{"funder_name":"Fidelity Biosciences","grant_id":"","title":null},{"funder_name":"Harvard NeuroDiscovery Center","grant_id":"","title":null}],"total_grants":32,"fwci":15.8319,"citation_percentile":0.99563193,"influential_citations":0,"citation_trend":[{"year":2018,"count":5},{"year":2019,"count":30},{"year":2020,"count":39},{"year":2021,"count":31},{"year":2022,"count":40},{"year":2023,"count":43},{"year":2024,"count":28},{"year":2025,"count":45},{"year":2026,"count":29}],"oa_status":"green","license":"other-oa","oa_locations":[{"url":"https://cris.maastrichtuniversity.nl/en/publications/eafec608-d546-4ac8-97fc-6a02be568b13","host_type":"repository"},{"url":"https://cris.maastrichtuniversity.nl/en/publications/eafec608-d546-4ac8-97fc-6a02be568b13","host_type":"repository"},{"url":"https://api.elsevier.com/content/article/PII:S1552526018301328?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1552526018301328?httpAccept=text/plain","host_type":"publisher"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2018.04.010","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.04.010","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1016/j.jalz.2018.04.010","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/am-pdf/10.1016%2Fj.jalz.2018.04.010","host_type":"publisher"},{"url":"https://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.04.010","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jalz.2018.04.010","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29803541","host_type":"repository"},{"url":"http://hdl.handle.net/2078.1/198519","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6131023","host_type":"repository"}],"fields_of_study":["Dementia and Cognitive Impairment Research","Alzheimer's disease research and treatments","Cancer-related cognitive impairment studies"],"mesh_terms":["Aged","Aged, 80 and over","Alzheimer Disease","Brain","Female","Humans","Male","Risk Factors","Sex Factors","Cohort Studies","Amyloid beta-Peptides","Disease Progression","Apolipoprotein E4","Cognitive Dysfunction","Prodromal Symptoms"],"keywords":["Cognitive decline","Apolipoprotein E","Dementia","Context (archaeology)","Alzheimer's Disease Neuroimaging Initiative","Cognition","Neuroimaging","Pittsburgh compound B","Apolipoprotein B","Psychology","Positron emission tomography","Biomarker","Disease","Medicine","Internal medicine","Gerontology","Psychiatry","Neuroscience","Cholesterol","Biology","Sex","Amyloid","apoE","Gender","Preclinical Alzheimer's Disease"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-26T10:30:08.482591Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}